alpha-aminopyridine has been researched along with Dermatoses in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Duong, VH; Kallen, ME; Koka, R; Sanchez-Petitto, G; Singh, Z; Yared, JA; Zaman, QU | 1 |
| Bogdanos, DP; Mavropoulos, A; Sakkas, LI | 1 |
| Bahjat, FR; Deng, GM; Liu, L; Pine, PR; Tsokos, GC | 1 |
1 review(s) available for alpha-aminopyridine and Dermatoses
| Article | Year |
|---|---|
Phosphodiesterase 4 Inhibitors in Immune-mediated Diseases: Mode of Action, Clinical Applications, Current and Future Perspectives.
Topics: Aminopyridines; Autoimmune Diseases; Benzamides; Boron Compounds; Cyclopropanes; Eye Diseases; Humans; Immunologic Factors; Intestinal Diseases; Phosphodiesterase 4 Inhibitors; Skin Diseases; Thalidomide | 2017 |
2 other study(ies) available for alpha-aminopyridine and Dermatoses
| Article | Year |
|---|---|
Teenage mutant neutrophilic precursors: Leukemia cutis with IDH2 mutation on enasidenib therapy.
Topics: Aminopyridines; Cellulitis; Humans; Isocitrate Dehydrogenase; Leukemia, Myeloid, Acute; Male; Middle Aged; Mutation; Neutrophils; Prognosis; Skin Diseases; Triazines | 2020 |
Suppression of skin and kidney disease by inhibition of spleen tyrosine kinase in lupus-prone mice.
Topics: Aminopyridines; Animals; Disease Models, Animal; Enzyme Inhibitors; Female; Lupus Erythematosus, Systemic; Lupus Nephritis; Lymph Nodes; Mice; Mice, Inbred MRL lpr; Mice, Knockout; Morpholines; Oxazines; Prodrugs; Pyridines; Pyrimidines; Receptor Protein-Tyrosine Kinases; Skin Diseases | 2010 |